Abel Hall LLC’s Sanofi SNY Stock Holding History

Abel Hall LLC’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$504K	Sell	12,219 -5,602	-31%	-$244K	0.09%	218
2026 Q2	$760K	Buy	17,821 +3,456	+24%	+$154K	0.13%	123
2026 Q1	$692K	Buy	14,365 +6,688	+87%	+$312K	0.15%	118
2025 Q4	$372K	Sell	7,677 -496	-6%	-$24.6K	0.09%	248
2025 Q3	$386K	Buy	+8,173	New	+$394K	0.16%	124
2025 Q2	–	Sell	-4,448	Closed	-$247K	–	321
2025 Q1	$247K	Sell	4,448 -6,542	-60%	-$354K	0.15%	131
2024 Q4	$530K	Buy	10,990 +194	+2%	+$9.9K	0.34%	42
2024 Q3	$622K	Buy	10,796 +534	+5%	+$28.8K	0.41%	36
2024 Q2	$498K	Sell	10,262 -319	-3%	-$15.4K	0.35%	45
2024 Q1	$514K	Sell	10,581 -351	-3%	-$17.1K	0.38%	40
2023 Q4	$544K	Buy	+10,932	New	+$535K	0.46%	33

Other funds holding SNY

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Foundation Resource Management Little Rock, Arkansas $939M AUM 37.7% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Abel Hall LLC's SNY Position: Q3 2026 in Review

Abel Hall LLC reduced its Sanofi (SNY) stake by 31% in Q3 2026, selling an estimated $244K and leaving 12,219 shares worth $504K. The position accounts for 0.09% of the portfolio, ranked #218.

Abel Hall LLC first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $760K in Q2 2026. 197 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

Abel Hall LLC held 12,219 shares of Sanofi worth $504K as of Q3 2026.
Abel Hall LLC sold 5,602 Sanofi shares in Q3 2026, an estimated $244K.
Sanofi made up 0.09% of Abel Hall LLC's portfolio in Q3 2026, its #218 holding.
Abel Hall LLC first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
Abel Hall LLC's Sanofi position peaked at $760K in Q2 2026.
197 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.